Medical Advisory Board

The Allo Hope Foundation’s Medical Advisory Board consists of specialized healthcare providers who are active in the treatment and research of maternal alloimmunization and Hemolytic Disease of the Fetus and Newborn. The Medical Advisory Board provides subject matter expertise, highlights needs from the healthcare community, and ensures that the Allo Hope Foundation is apprised of them most current research and treatments. We are very thankful for our Medical Advisory Board members and their invaluable contributions to the Foundation.

Kara B. Markham, MD

Kara Beth Markham, M.D. joined the Maternal Fetal Medicine division at the University of Cincinnati in August of 2018, also devoting a portion of her clinical time to the Cincinnati Children’s Fetal Center. Born and raised in West Virginia, she obtained her undergraduate degree from Denison University followed by completion of her medical degree at the University of Michigan. She then completed both her obstetrics and gynecology residency and her maternal fetal medicine fellowship at The Ohio State University. During her training, she was fortunate to have Dr. Richard O’Shaughnessy as her mentor in the field of alloimmunization and hemolytic disease of the fetus, sparking an interest in this complex medical condition.

In addition to her continued clinical work, Dr. Markham will soon complete a masters in bioethics, and she plans to use this degree to explore the ethical issues inherent to the field of fetal medicine. She is also interested in psychosocial aspects impact of such care on families, fully recognizing the anxiety that many women face while pregnant with a baby that is at risk for or is known to have hemolytic anemia. Through studying these mental effects upon patients, she hopes to better care for women in a holistic manner.

Kenneth J Moise Jr, M.D.

Co-Director, The Fetal Center

  • Professor, Department of Obstetrics, Gynecology & Reproductive Sciences
  • Professor, Department of Pediatric Surgery

Kenneth J. Moise Jr, M.D. is a professor in the Division of Maternal-Fetal Medicine in the Department of Obstetrics and Gynecology, and Reproductive Sciences and in the Department of Pediatric Surgery at The John P. and Kathrine G. McGovern Medical School at The University of Texas Health Science Center at Houston (McGovern Medical School at UTHealth). He currently sees patients in The Fetal Center at Children’s Memorial Hermann Hospital in Houston.

Dr. Moise completed his residency in Obstetrics and Gynecology at Vanderbilt University followed by a fellowship in Maternal-Fetal Medicine at Baylor College of Medicine. Dr. Moise is the former Director of Maternal-Fetal Medicine at Baylor College of Medicine and at the University of North Carolina School of Medicine. He is the former President of the International Fetal Medicine and Surgery Society and served for many years as the Treasurer/Secretary of that organization. He is a founding member of the North American Fetal Treatment Network (NAFTNet) having served on its executive board and its steering committee. He is board certified in general Obstetrics and Gynecology as well as Maternal-Fetal Medicine.

Dr. Moise’s interest in fetal therapy spans a 30 year period. He is recognized world-wide for his contributions in the fetal treatment of Rh disease including the development of middle cerebral artery Doppler for the non-invasive detection of fetal anemia and the use of free fetal DNA to determine the fetal RND status in the U.S.. He was instrumental in the formation of the three fetal centers – the Center for Maternal and Infant Health at the University of North Carolina, the Texas Children’s Fetal Center in Houston and The Fetal Center at Children’s Memorial Hermann Hospital in Houston. In 2019, he was awarded the Lifetime Achievement Award by the Society for Maternal-Fetal Medicine for his work in Hemolytic Disease of the Fetus and Newborn.

Thomas N. Trevett Jr, MD

Dr. Trevett joined Georgia Perinatal Consultants in April of 2008. He received his undergraduate degree from the College of the Holy Cross in 1994 and his medical degree from the State University of New York at Buffalo. He performed his Obstetrics and Gynecology residency at the University of California, San Diego, graduating in 2002, then went on to complete a three-year fellowship in Maternal Fetal Medicine at the University of North Carolina, Chapel Hill in 2005.

During his fellowship, Dr. Trevett published numerous articles and book chapters, and gave multiple invited lectures. He was also given an award for outstanding research at the 2004 Annual Convention of the Society of Maternal Fetal Medicine for his research involving the use of Phenobarbital to prevent neonatal exchange transfusions in pregnancies complicated by isoimmunization. He is currently an invited reviewer for the American Journal of Obstetrics and Gynecology.

Dr. Trevett enjoys all aspects of Maternal-Fetal Medicine, especially prenatal diagnosis with ultrasound and critical care for pregnant women. His practice is dedicated to improving the health and well-being of pregnant women and their babies

Saul Snowise, MD

Dr. Snowise is the Medical Director Midwest Fetal Care Center, as well as part of Carol L. Wells Endowed Chair in Fetal Surgery. His specialities include maternal-fetal medicine and fetal inervention. After attending medical school at the University of Conneticut, Dr. Snowise went on to complete his OBGYN residency at Albert Einstein College of Medicine in the Bronxy, New York. Dr. Snowise completed his MFM Fellowship at the National Women's Hospital in Auckland, New Zealand before traveling to the University of Texas in Houston to do his Fetal Intervention Fellowship.

Enrico Lopriore, MD

Dr. Lopriore is a professor of neonatology and fetal medicine and head of the Neonatal Intensive Care Unit at the Leiden University Medical Center (LUMC). Dr. Lopriore graduated from medical school at Leidin University in 2006. In 2016, he was appointed Professor in Neonatology of the Leiden University Medical Center. His research focuses mainly on the origin, management and outcome in various fetal disorders, including complicated monochorionic twins (with TTS, TAPS, or sIUGR) and fetal hematologic diseases (anemia or thrombocytopenia). The ultimate goal of his research is to improve perinatal survival and in particular the long-term outcome in these vulnerable babies.